American Journal of Psychiatry · 1990 · 119 citations · 0 references
MedicineNeurologyPharmacotherapyMovement DisordersMovement Disorder PharmacotherapyParkinsonian DisordersVitamin E DeficiencyAbnormal Involuntary Movement ScaleDyskinesia ReductionPlacebo ComparatorsTardive Dyskinesia TreatmentTardive Dystonia
Eight subjects with persistent tardive dyskinesia were treated with vitamin E and placebo in a randomized, double-blind crossover study. Their mean score on the Abnormal Involuntary Movement Scale (AIMS) was significantly lower after treatment with vitamin E than after placebo administration.